Journal ArticleOpen Access
Stem Cell Therapy for Cirrhosis of Liver in Bangladesh: Specific Design Compatible for Developing Country
Authors
Author Affiliations
Ibrahim Cardiac Hospital & Research Institute, Shaheed Suhrawardy Medical College, Ehime University, Bangabandhu Sheikh Mujib Medical University, ...
Published InEuroasian Journal of Hepato-Gastroenterology
Year2018
Citations6
Abstract
AIMS AND OBJECTIVES: To assess the safety and efficacy of stem cell therapy in patients with cirrhosis of the liver (LC) in the context of developing country with limited facilities for cell-based therapy and advanced technologies. MATERIALS AND METHODS: A total of 34 patients received granulocyte colony-stimulating factor at a dose of 30 IU, daily for 2 to 11 days to upregulate the numbers of white blood cells and stem cells. Subsequently, stem cells were isolated from the peripheral blood of LC patients in a closed chamber using a harvesting machine. Variable amounts of autologous stem cells were injected to LC patients for once. The patients were followed for 3 months and various factors related to safety and parameters of…
View at Publisher
BORR does not host full-text PDFs. The button above takes you to the original publisher.